This inventor holds 1 USPTO granted patent. Top assignee: F. Hoffmann-La Roche Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: John A Hall: Innovator in Recombinant Protein Technology
Introduction
John A Hall is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
John A Hall holds a patent for a "Composition Comprising Recombinant GPIBA Receptor Protein." This invention represents a step forward in the understanding and application of recombinant proteins in therapeutic settings. His innovative approach has the potential to impact treatments related to blood disorders.
Career Highlights
John A Hall is associated with F. Hoffmann-La Roche AG, a leading global healthcare company. His role in the organization has allowed him to work on cutting-edge research and development projects. His expertise in recombinant proteins has positioned him as a valuable asset in the field of biotechnology.
Collaborations
John has collaborated with esteemed colleagues, including Elizabeth Booth and Virginia Montanini. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
John A Hall's contributions to recombinant protein technology exemplify the spirit of innovation in the biotechnology sector. His work not only advances scientific knowledge but also holds promise for future medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile